A 68-year-old man with prostate cancer develops penile metastases, a rare but serious complication, reinforcing the need for ...

Adding an immune checkpoint inhibitor (ICI) to chemotherapy for advanced prostate cancer failed to improve survival as ...

This groundbreaking finding suggests that Telomir-1 may selectively benefit healthy cells while suppressing malignant growth, challenging the assumption that telomere-elongating drugs inherently ...

When it comes to lung cancer, we know of more than 30 substances that are carcinogenic. But when researchers began ...

A new large-scale study co-led by UCLA Health Jonsson Comprehensive Cancer Center investigators provides the strongest ...

A shorter, higher-dose radiation treatment for prostate cancer is just as safe and effective as conventional radiotherapy, ...

A study led by UCLA investigators shows that artificial intelligence (AI) could play a key role in improving treatment ...

Mateship, support, information: this and more are what two cancer survivors are hopeful a dedicated prostate cancer nurse can ...

Currently, doctors usually check PSA levels about six to eight weeks after surgery. However, a new study from Mass General ...

A new artificial intelligence tool could help doctors determine which prostate cancer patients are most likely to benefit ...

Zydus Lifesciences received final USFDA approval to manufacture Apalutamide tablets for prostate cancer, following last ...

Dr. Chandler Park sat down for an interview with CURE® to discuss the biggest takeaway from the 2025 ASCO GU Symposium in ...